BDSX FY 2020 Earnings — Biodesix, Inc. Revenue & Financial Results | Market Cap Arena

BDSXBiodesix, Inc.

$151M

FY 2020 Earnings

Healthcare Medical - Diagnostics & Research

Income Statement

Revenue

$46M+85.6% YoY

Gross Profit

$24M51.7% margin

Operating Income

-$23M-50.3% margin

Net Income

-$31M-68.8% margin

EPS (Diluted)

$-6.48

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$24M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$121M

Total Liabilities

$80M

Stockholders' Equity

$41M

Cash & Equivalents

$62M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$46M	$25M	+85.6%
Gross Profit	$24M	$18M	+27.5%
Operating Income	-$23M	-$27M	+14.2%
Net Income	-$31M	-$31M	-2.0%